Junyan A. Ji
Junyan A. Ji publishes mostly in Molecular Biology, Spectroscopy and Radiology, Nuclear Medicine and Imaging, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Analytical Chemistry and Chromatography.
- World rank
- #673,775 of 7,710,434 ranked researchers
- Rank in United States
- #228,634 of 1,627,098
- Works
- 27
- Citations
- 1.8k
- Citations per work
- 65.3
What does Junyan A. Ji research?
Junyan A. Ji's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Chemistry (17%), Medicine (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences935.1%
- Everything else828.5%
- Physical Sciences622.1%
- Chemistry516.9%
- Engineering15.2%
- Health Sciences414.3%
- Medicine414.3%
- 1Molecular Biology30% of their works
- 2Spectroscopy17% of their works
- 3Radiology, Nuclear Medicine and Imaging10% of their works
- 4Pharmaceutical Science5% of their works
- 5Biomedical Engineering5% of their works
- 6Oncology4% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Analytical Chemistry and Chromatography
- Mass Spectrometry Techniques and Applications
- Viral Infectious Diseases and Gene Expression in Insects
- Advanced Proteomics Techniques and Applications
- HER2/EGFR in Cancer Research
- Advancements in Transdermal Drug Delivery
Which keywords describe Junyan A. Ji's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Protein Aggregation, Glycosylation, Antibody Engineering, Fc Receptors and Mass Spectrometry.
- Solid Lipid Nanoparticles
- Quantitative Analysis
- HER2
- Recombinant Protein
- Liquid Chromatography
- Electrospray
- Monoclonal Antibody
- Mass Spectrometry
- Antibody Engineering
- Protein Aggregation
- Therapeutic Antibodies
- Monoclonal Antibodies
- Biopharmaceuticals
- Glycosylation
- Fc Receptors
- Proteomics
- Chiral Separation
- Ionization
- Mammalian Cells
- Breast Cancer
- Protein Identification
- Microneedles
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Monoclonal Antibodies222 topics
- Therapeutic Antibodies222 topics
- Biopharmaceuticals141 topic
- Protein Aggregation141 topic
- Glycosylation122 topics
- Antibody Engineering81 topic
- Fc Receptors81 topic
- Mass Spectrometry82 topics
- Proteomics82 topics
- Monoclonal Antibody72 topics
- Chiral Separation51 topic
- Electrospray51 topic
- Ionization51 topic
- Liquid Chromatography51 topic
- Mammalian Cells41 topic
- Recombinant Protein41 topic
- Breast Cancer31 topic
- HER231 topic
- Protein Identification31 topic
- Quantitative Analysis31 topic
- Microneedles21 topic
- Solid Lipid Nanoparticles21 topic
Where does Junyan A. Ji work?
Junyan A. Ji's main affiliation in the publication record is Pharmaceutical Product Development (United States), United States.
How many publications and citations does Junyan A. Ji have?
OpenAlex counts 27 works and 1,763 citations for Junyan A. Ji, an h-index of 20, ranking #673,775 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Junyan A. Ji. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.